Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients

Journal of Clinical Laboratory Analysis

Volumn 20, Issue 6, 2006, Pages 260-265

  Chen, Rong Hsing ^a   Chang, Chwen Tzuei ^a   Chen, Wei Chi ^a   Tsai, Chang Hai ^a,b   Tsai, Fuu Jen ^a,c  

^a China Medical University Hospital   (China)

^b ASIA UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Hashimoto's thyroiditis; Polymorphism; Proinflammatory cytokine

Indexed keywords

CYTOKINE; GENOMIC DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC MARKER; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HASHIMOTO DISEASE; HUMAN; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROINFLAMMATORY CYTOKINE GENE; PROMOTER REGION; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TUMOR NECROSIS FACTOR ALPHA GENE; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 33845234043     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20152     Document Type: Article

References (26)

1. Doniach D. Hashimoto's thyroiditis and primary myxedema viewed as separate entities. Eur J Clin Invest 1981;11:245-246.
2. Woolner LB, McConahey WM, Beahrs OH. Struma lymphomatosa [Hashimoto's thyroiditis] and the related thyroidal disorder. J Clin Endocrinol Metab 1959;19:53-83.
3. Martin A, Davies TF. T cells and human autoimmune thyroid disease: emerging data show lack of need to invoke suppressor T-cell problem. Thyroid 1992;2:247-261.
4. Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003;148:1-9.
5. Giordano C, Stassi G, De Maria R, et al. Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997;275:960-963.
6. Chiovato L, Bassi P, Santini F, et al. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endicrinol Metab 1993;77:1700-1705.
7. Kelso A. Cytokines: principles and prospects. Immunol Cell Biol 1998;76:300-317.
8. Rosenwasser LJ. Biologic activities of IL-1 and its role in human disease. J Allergy Clin Immunol 1998;102:344-350.
9. Kopf M, Le Gros G, Coyle AJ, Kosco-Vilbois M, Brombacher F. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol Rev 1995;148:45-69.
10. Kissonerghis AM, Grubeck-Loebenstein B, Feldmann M, Londei M. Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre. Autoimmunity 1989;44:255-266.
11. Weetman AP. Autoimmune thyroiditis: predisposition and pathogenesis. Clin Endocrinol (Oxf) 1992;36:307-323.
12. Wan XL, Kimura Dong RP, Honda K, Tamai H, Sasazuki T. HLA-A and DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol 1995;42:131-136.
13. Yanagawa T, Taniyama M, Enomoto S, et al. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997;7:843-846.
14. Bougacha-Elleuch N, Rebai A, Mnif M, et al. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF -308 gene polymorphism. J Autoimmun 2004;23:75-80.
15. Chen RH, Chen WC, Chang CT, Tsai CH, Tsai FJ. Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J Clin Lab Anal 2005;19:133-138.
16. Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42:1093-1100.
17. Chung HW, Seo JS, Hur SE, et al. Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet 2003;48:243-248.
18. Galbraith GM, Pandey JP. Tumor necrosis factor alpha (TNF-α) gene polymorphism in alopecia areata. Hum Genet 1995;96:33-436.
19. Taga T, Kawanishi Y, Hardy RR, Hirano T, Kishimoto T. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution and regulation of their expression. J Exp Med 1987;166:967-981.
20. Tominaga T, Yamashita S, Nagayama Y, et al. Interleukin 6 inhibits human thyroid peroxidase gene expression. Acta Endocrinol (Copenh) 1991;124:290-294.
21. Tsukamoto K, Haruta K, Shiba T, Emi M. Isolation and mapping of a polymorphic CA repeat sequence at the human interleukin 6 locus. J Hum Genet 1998;43:71-72.
22. Chapman CM, Beilby JP, Humphries SE, Palmer LJ, Thompson PL, Hung J. Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J 2003;24:1494-1499.
23. Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G. Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 1994;8:1280-1284.
24. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma level, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-1376.
25. Tsukamoto K, Ohta N, Shirai Y, Emi M. A highly polymorphic CA repeat marker at the human tumor necrosis factor alpha (TNFA alpha) locus. J Hum Genet 1998;43:278-279.
26. Blakemore AI, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995;80:111-115.